Introduction
The remarkable complexity of oligosaccharide structures found on vertebrate cells results from the concerted action of glycosyltransferase enzymes (Joziasse, 1992; Stanley and Ioffe, 1995; Varki and Marth, 1995; Whitfield and Douglas, 1996) , several of which were first identified and characterized by Robert Hill (Paulson et al, 1977; Paulson et al, 1978; Beyer et al, 1979; Rearick et al, 1979; Sadler et ai, 1979 Sadler et ai, , 1982 . Together with the structural characterization of naturally occurring oligosaccharides, the study of these enzymes has led to the definition of the major structural motifs of vertebrate sugar chains (Cummings, 1992; Kobata and Takasaki, 1992; Varki and Freeze, 1994; Varki and Marth, 1995) . These motifs can be divided into (1) the core regions unique for each class of glycoconjugate (e.g., the Chitobiosyl-N-Asn-linkage region); and (2) the outer chains (e.g., type 1 and 2 lactosamine units with sialylation and/or fucosylation) that can be shared to varying extents by the different core classes (Cummings, 1992; Kobata and Takasaki, 1992; Varki and Freeze, 1994; Varki and Marth, 1995) . Vertebrate cells utilize a relatively limited subset of the monosaccharides known to exist in nature, and in only some of the many possible combinations. However, several unusual variations of the typical structures exist, as well as a variety of specific modifications of the individual monosaccharide units. Hypothesizing that such subtle variations and modifications are more likely to mediate specific biological functions (Varki, 1993) , we have paid special attention to their existence, structure and biosynthesis. Here I briefly describe some examples that my group has studied over the past decade. 9(7)-O-Acetylation of sialic acids This was once considered an uncommon modification of sialic acids, only present on salivary mucins and neural gangliosides (Schauer, 1991; Varki, 1992) . However, newly developed methods for the release, purification, and analysis of sialic acids from biological sources indicate that this is not the case (Manzi et al, 1990; Klein et al., 1994; Reuter and Schauer, 1994) . For example, we found that the membrane glycoproteins of rat liver (one of the most commonly used model systems for the study of oligosaccharide biosynthesis) have -20-30% of O-acetylation at the 7-or 9-positions of sialic acids (Butor et al, 1993) . Moreover, the subcellular distribution of these modifications fits predictions derived from prior information on their enzymology and chemistry (7-O-acetyl groups are enriched in acidic internal compartments, while 9-O-acetyl group predominate on the cell surface).
Other studies using monoclonal antibodies have indicated that (7)9-O-acetylated siaJic acids are selectively expressed on certain gangliosides in neural tissues and on some types of leukocytes (Schauer, 1991; Varki, 1992) . Of recent interest is the identification that the CD60 antigens of human blood leukocytes are (7)9-O-acetylated forms of the ganglioside GD3 (Fox et al, 1990b; Kniep et al, 1993; Rieber and Rank, 1994; Zimmer et al, 1994) . It has been shown by others that ligation of this glycosphingolipid by specific monoclonal antibodies results in facilitation of T-cell activation (Fox et al, 1990a) . Interestingly, an antibody that preferentially bound the 7-Oacetyl form was the most potent at inducing this activation (Kniep et al, 1995) .
With the exception of these ganglioside antigens, it was previously not possible to directly detect 9-O-acetyl sialic acids on cell surfaces and tissue sections. We and others (Muchmore and Varki, 1987; Zimmer et al, 1992 Zimmer et al, , 1994 had suggested the use of the whole influenza C virion as a probe for this purpose. This virus carries a membrane-bound hemagglutinin-esterase (CHE), which can both detect and cleave 9-O-acetyl-residues on sialic acids, regardless of the underlying oligosaccharide structure. However, the whole virions are unstable, are subject to steric hindrance in binding, and are impractical for many applications. To address this deficiency, we prepared a recombinant soluble form of the CHE wherein the C-terminal transmembrane and cytoplasmic domains are replaced by the Fc portion of human IgG, and the potential fusion function of the protein is eliminated by a point mutation . Irreversible inactivation of the esterase active site unmasks stable recognition activity, giving a molecule that binds specifically to 9-O-acetylated sialic acids. This probe demonstrates widespread but selective expression of 9-O-acetylated sialic acids in certain cell types, with patterns of polarized or gradient expression . Using this probe, we also found that natural ligands of the B cell adhesion molecule CD22 can be masked by 9-O-acetylation of sialic acids (Sjoberg et al, 1994) , and that Chinese hamster ovary (CHO) cells have an endogenous O-acetyltransferase that becomes functionally activated upon transfection with a cDNA encoding the (a2-6 sialyltransferase specific for type 2 lactosamines (Shi et al, 1996) . The latter work confirms prior predictions that the 9(7)-O-acetyltransferases of vertebrate cells are sialic acid linkage-specific in their action, and raises the possibility that there is a family of such enzymes yet to be isolated and cloned.
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De-N-acetyl sialic acids
In natural systems, the amino group at the 5-position of neuraminic acid residues is usually assumed to be either acylated (N-acetyl or N-glycolyl) or replaced by a hydroxyl group (as in keto-deoxy-nonulosonic acid, KDN) (Schauer, 1991; Troy, 1992; Varki, 1992; Sato et al., 1993) . However, earlier studies had suggested the possibility that a free amino group might be present on the sialic acids of some gangliosides (Hanai et al., 1988; Nores et al, 1989) . To pursue this possibility, we collaborated with Tai and colleagues to raise specific monoclonal antibodies against semisynthetically prepared de-Nacetyl-GM3 and de-N-acetyl-GD3. These antibodies gave low and variably detectable levels in cultured human melanoma cells (Sjoberg et al., 1995) . Further studies showed that the tyrosine kinase inhibitor genistein and the microtubule inhibitor nocodazole caused an accumulation of these molecules on the cell surface, making them more easily detectable (Sjoberg et al., 1995) . This effect appears to be related to the cell shape change that occurs when these agents block cells in the G2M phase of the cell cycle. Studies are currently underway to conclusively demonstrate the structures of these gangliosides, and to elucidate their subcellular localization, biosynthesis and functions.
Other novel sialic acids
Of all the monosaccharides in vertebrate oligosaccharides, the sialic acids appear most prone to substitution (Schauer, 1991; Troy, 1992; Varki, 1992; Sato et al., 1993) . The list of novel modifications of sialic acids continues to grow. An example is the recent demonstration by others of 9-O-sulfo-N-glycolylneuraminic acid in sea urchin eggs (Kitazume et al., 1996) . While exploring the biosynthetic function of the rat liver Golgi apparatus, we recently found evidence for even more diversity. When rat liver subcellular preparations enriched in Golgi compartments are incubated with CMP-[9-
3 H]N-acetyl-neuraminic acid, the label is efficiently transferred to endogenous acceptors that are only within the lumen of intact compartments, which are of correct topological orientation (Hayes and Varki, 1993b) . Thus, this in vitro system recapitulates the in vivo glycosylation mechanism, but eliminates the dynamic variable of ongoing transport. Peptide:N-glycosidase F digestion released -90% of the incorporated label, indicating that most of the sialylation had occurred on endogenous N-linked oligosaccharide acceptors. Upon HPLC analysis of sialic acids released from these oligosaccharides, two surprises were encountered (Hayes and Varki, 1993b ). First, the expected level of (7)9-0-acetylation was not found. This was true even upon addition of excess of the acetyl donor acetyl-CoA, suggesting that the responsible O-acetyltransferases might be in a separate compartment. Second, -20% of 3 H label released by sialidase did not elute at the position expected for [
3 H]N-acetyl-neuraminic acid, but was scattered through several aberrantly eluting peaks. Most peaks were unchanged by prior base treatment, indicating that they are not due to O-acetylation. Thus, during these short (10-20 min) incubations, a significant portion of the [
3 H]N-acetyl-neuraminic acid transferred from the sugar nucleotide donor is modified by unknown enzymes within the Golgi lumen. The nature of these novel sialic acids is under investigation.
Mild acid labile GalNAc residues on N-linked oligosaccharides
When UDP-[6-3 H]GalNAc is incubated with subcellular preparations enriched in Golgi compartments, some of the label is transferred to endogenous acceptors within the lumen of intact compartments, which are of correct topological orientation. A portion of this label can be released by PNGase F, indicating that [ 3 H]GalNAc had been transferred to some relinked oligosaccharides on endogenous acceptors. This is not entirely surprising, since a-and B-linked GalNAc have been previously reported on N-linked chains (Cummings, 1992; Kobata and Takasaki, 1992; Varki and Freeze, 1994; Baenziger, 1994 ). However, a major portion of this 3 H label was found to be mild acid labile, with acid release kinetics typical of a phosphodiester linkage. Direct analysis of the released label indicated that it remained in [ 3 H]GalNAc, and thus could not be explained as previously described GlcNAc-P-Man linkages on high mannose oligosaccharides of lysosomal enzymes (Hayes and Varki, 1993a) . Furthermore, unlike the case with GlcNAc-P-Man, this modification was found only on complex type chains (not binding to ConA), and some of them also carried sialic acids. The nature of these novel linkages and the proteins to which they are attached is under exploration. If this structure is confirmed, it would add to the list of previously described phosphodiesters in animal systems, that include GlcNAc-P-Man of lysosomal enzymes (Kornfeld and Mellman, 1989 ), Glc-P-Man on phosphoglucomutase (Dey et al., 1994) , GlcNAc-P-Ser on Dictyostelium (Freeze and Ichikawa, 1995) , and Man-P-Man in yeast (Hernandez etai, 1989) .
Unsubstituted glucosamine residues on endothelial heparan sulfates
Known biosynthetic pathways of heparan sulfate (HS) chains indicate that all glucosamine amino groups must be either Nacetylated or N-sulfated. This is because the de-N-acetylation and N-sulfation reactions are known to be catalyzed by the same polypeptides (Bame et al., 1991 (Bame et al., , 1994 Wei et al, 1993; Eriksson et al., 1994; Mandon et al, 1994; Orellana et al, 1994) . However, L-selectin binding HS chains from endothelial cells have some unsubstituted amino groups that could not be ascribed to any in vitro processing artifact (NorgardSumnicht and Varki, 1995) . These free amino groups (present on about every 20-50 disaccharide units) are also found in HS chains from human umbilical vein endothelial cells. However, they are not found in HS chains from CHO cells, indicating that they are not random errors that routinely occur during the biosynthesis of HS chains. The mechanism of generation of these unusual groups, and their distribution and function remain unknown. Others have recently reported detection of the same modification using a specific monoclonal antibody (Van den Born et al., 1995) . Interestingly, the epitope showed highly selective distribution relative to the overall distribution of HS chains in tissues like the kidney.
Unusual N-linked oligosaccharides from bovine lung
In earlier studies, we reported that calf pulmonary artery endothelial (CPAE) expressed a variety of sulfated N-linked sugar chains with unexpected structural features (Roux et al, 1988; Sundblad et al, 1988) . To pursue this further, we examined total anionic N-linked oligosaccharides released by PNGaseF from bovine lung, a rich source of endothelium (Norgard-Sumnicht et al., 1995) . We found that sialic acids, sulfates and phosphates account only for a minority of the anionic properties of these multi-antennary complex-type chains. The majority of the negative charge appears to be due to multiple carboxylic acid groups on as yet unidentified residues. The most highly charged N-linked oligosaccharides from the same source are similar in general structure to the corresponding ones we previously found in the cultured pulmonary artery endothelial cells , carrying chondroitin sulfate, heparin/heparan sulfate, or keratan sulfate glycosaminoglycan chains. A significant proportion of these molecules seem to have more than one type of glycosaminoglycan chain associated with them, presumably on multiple branches of a single N-linked core region (Norgard-Sumnicht et al., 1995) . The structural elucidation of these novel chains is under way.
Conclusions and future prospects
Modern-day scientists are often accused of not being able to 'see the forest for the trees', that is, we spend so much time focused on the details of our particular systems that we fail to see the bigger picture. However, I wonder if the opposite might be the case among those studying the biology of glycosylation, that is, are we missing the flowers because we are focusing mainly on the trees? The complexities of the known major pathways of vertebrate glycosylation are already so great that there are numerous structures to be studied, enzymes to be isolated, and genes to be cloned. Thus, it is tempting to ignore further minor variations and modifications that occur less frequently. Many examples presented above from our own work fall into this category and, for the most part, have not been related to any specific function. The same is true in a variety of novel oligosaccharide modifications that have not been dealt with in this brief overview. However, scientists who study plant or bacterial polysaccharides are quite used to dealing with a much larger variety of oligosaccharide structures and modifications. Moreover, the history of discovery in glycobiology indicates that such unusual features can serve to generate the specificity of carbohydrate protein interactions that mediate specific biological functions. Examples include the addition of phosphate esters to mannose residues (critical for targeting lysosomal enzymes to lysosomes) (Kornfeld and Mellman, 1989) , the addition of 3-O-sulfate esters to heparin (vital for high affinity binding to antithrombin III) (Lindahl et ai, 1979 (Lindahl et ai, , 1980 Bourin and Lindahl, 1993; Razi and Lindahl, 1995) , and the addition of sulfate esters to GalNAc residues on pituitary glycoprotein hormones (required for recognition by a specific liver receptor that controls plasma levels) (Green et al., 1985; Baenziger, 1994 Baenziger, , 1996 . Of course, it does not follow that every unusual variation or modification will mediate a very specific biological function. For example, a particular unusual modification may well be an evolutionary relic left behind from a past time when the vertebrate organism in question evaded recognition by a now-extinct parasite. However, faced with the daunting task of exploring the complex world of vertebrate glycosylation, it might be worthwhile to focus some time and effort on such 'flowers on the trees'.
